肖蓉, 李波. 单核细胞/高密度脂蛋白胆固醇比值与冠心病关系研究进展[J]. 心脏杂志, 2018, 30(6): 732-735. DOI: 10.13191/j.chj.2018.0173
    引用本文: 肖蓉, 李波. 单核细胞/高密度脂蛋白胆固醇比值与冠心病关系研究进展[J]. 心脏杂志, 2018, 30(6): 732-735. DOI: 10.13191/j.chj.2018.0173
    XIAO Rong, LI Bo. Research advances in relationship between monocyte/HDL-C ratio and coronary heart disease[J]. Chinese Heart Journal, 2018, 30(6): 732-735. DOI: 10.13191/j.chj.2018.0173
    Citation: XIAO Rong, LI Bo. Research advances in relationship between monocyte/HDL-C ratio and coronary heart disease[J]. Chinese Heart Journal, 2018, 30(6): 732-735. DOI: 10.13191/j.chj.2018.0173

    单核细胞/高密度脂蛋白胆固醇比值与冠心病关系研究进展

    Research advances in relationship between monocyte/HDL-C ratio and coronary heart disease

    • 摘要: 近年来冠心病发病率和死亡率逐渐增高,冠状动脉粥样硬化(AS)是冠心病的主要原因。AS的基本病理机制为炎症反应,单核细胞在炎症反应中起关键作用。高密度脂蛋白胆固醇(HDL-C)有抗炎、抗氧化、抗血栓等作用,单核细胞/HDL-C比值(MHR)作为新近出现的炎症指标,其方便、容易检测,在预测冠心病短期和长期不良事件中有重要意义。

       

      Abstract: In recent years, the incidence and mortality of coronary heart disease has increased gradually. Atherosclerosis is the main cause of coronary heart disease. The basic pathogenesis of atherosclerosis is inflammation and monocytes, which play a key role in inflammatory response. HDL-C has anti-inflammatory, antioxidant, and antithrombotic effect. Signficant research in short-term and long-term adverse events has been completed on the monocyte/HDL ratio, which is a new inflammation index and is convenient and easy to measure in the prediction of coronary heart disease.

       

    /

    返回文章
    返回